Outset Medical (OM) Net Equity Issued and Repurchased (2020)
Outset Medical's (OM) quarterly Net Equity Issued and Repurchased came in at $128.0 million in Q4 2020, up 1.02% on a QoQ basis from $126.8 million in Q1 2020.
Outset Medical (OM) Net Equity Issued and Repurchased (2020) Analysis & Trends
Outset Medical (OM) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $128.0 million in Q4 2020.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $128.0 million in Q4 2020; TTM through Sep 2022 was $128.0 million, a 0.0% change from a year earlier, with the FY2021 full-year figure at $149.1 million, down 41.49% from the prior year.
- Net Equity Issued and Repurchased for Q4 2020 stood at $128.0 million, up from $126.8 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for OM reached as high as $128.0 million in Q4 2020 and fell as low as $126.8 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 12.70 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | - |
| 10 | Outset Medical | 77,809.66 | -286.57 Mn | 12.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 128.05 Mn |
| Dec 31, 2020 | 128.05 Mn |
| Mar 31, 2020 | 126.76 Mn |
| Mar 31, 2020 | 126.76 Mn |